Congress of the European Crohn ’ s and Colitis Organisation ( ECCO ) in Vienna , Austria Chairperson :

Disclosure: Prof Panaccione has acted as a consultant and/or advisory board member for Abbott, AbbVie, ActoGeniX, AGI Therapeutics, Alba Therapeutics Albireo, Alfa Wasserman, Amgen, AM-Pharma BV, Anaphore, Aptalis, Astellas, AstraZeneca, Athersys, Atlantic Healthcare, Baxter, BioBalance, Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celek, Cellerix, Cerimon, ChemoCentryx, CoMentis, Cosmo Technologies, Coronado Biosciences, Cubist, Cytokine PharmaSciences, Eagle, Eisai Medical Research, Elan, EnGene, Eli Lilly, Enteromedics, Exagen Diagnostics, Ferring, Flexion Therapeutics, Funxional Therapeutics, Genentech, Genzyme, Gilead, Given Imaging, GlaxoSmithKline, Hospira, Human Genome Sciences, Ironwood, Janssen, KaloBios, Lexicon, Lycera, Meda, Merck & Co., Merck Research Laboratories, MerckSerono, Millennium, Nisshin Kyorin, Novo Nordisk, NPS Pharmaceuticals, Optimer, Orexigen, PDL Biopharma, Pfizer, Procter and Gamble, Prometheus Laboratories, ProtAb, Purgenesis Technologies, Receptos, Relypsa, Salient, Salix, Santarus, Shire Pharmaceuticals, Sigmoid Pharma, Sirtris (a GSK company), S.L.A. Pharma (UK), Targacept, Takeda, Teva, Therakos, Tillotts, TxCell SA, UCB Pharma, Vascular Biogenics, Viamet, and Warner Chilcott UK; and as a speaker for AbbVie, Aptalis, AstraZeneca, Ferring, Janssen, Merck, Prometheus, Shire, and Takeda. Dr Halfvarson has acted as a consultant and/or received speaker fees from AbbVie, Celgene, Hospira, Janssen, Medivir, MSD, Pfizer, Renapharma-Vifor, Sandoz, Shire, Takeda, and Tillotts. Dr Bossuyt has received advisory board and/or speaker fees from AbbVie, Dr Falk Benelux, Hospira, Janssen, MSD, Mundipharma, Pfizer, Roche, Takeda, and Vifor Pharma.